AstraZeneca accelerates testing of COVID-19 antibody treatments

AstraZeneca said on Tuesday it expects to move two COVID-19 antibody therapies it has licensed from U.S. researchers into clinical studies in the next two months as the drugmaker ramps up efforts to help combat the health crisis.